31 results
DEFA14A
AGIO
Agios Pharmaceuticals Inc
10 May 21
Additional proxy soliciting materials
4:18pm
to them, including executive compensation matters, as we did following the say on pay vote at last year’s annual meeting of stockholders – and following … to vote “FOR” our Say on Pay proposal (proposal 2).
The Board remains committed to an executive compensation program that aligns with the interests of our
DEF 14A
qob xx2shu5b3qce2u3
7 Apr 14
Definitive proxy
12:00am
S-1
6vhse
10 Jun 13
IPO registration
12:00am
424B4
sk0ua1p kdki
24 Jul 13
Prospectus supplement with pricing info
12:00am
10-Q
hyd 2a26yfqj7
5 Sep 13
Quarterly report
12:00am
10-K
vliwedjj885ll5h
18 Mar 14
Annual report
12:00am
424B4
th07elwny0et25gbnc9u
24 Apr 14
Prospectus supplement with pricing info
12:00am
DEFA14A
EX-2.1
fm0e3 vnxk
21 Dec 20
Additional proxy soliciting materials
9:17pm